You are here
It is our pleasure to invite you to attend the ninth Prostate Cancer Debate in Lisbon on 15–16 October 2015, supported by the Janssen Pharmaceutical Companies of Johnson & Johnson in EMEA.
There have been numerous advances in the treatment of prostate cancer that have resulted in improvement in patient outcomes. The upcoming Prostate Cancer Debate will provide an opportunity to review the latest clinical data and discuss the practicalities of patient management in clinical practice.
The program for the Prostate Cancer Debate will include plenary sessions updating you on the latest data on the treatment of prostate cancer. Panel discussion sessions will provide an opportunity to discuss how these data might affect daily clinical practice. There will also be workshop sessions, which will provide you with an opportunity to discuss patient management in smaller groups of delegates, with international experts treating prostate cancer. Throughout the program you will be invited to interact with the faculty, using interactive keypads to send your views and ask questions.
We very much look forward to welcoming you to Lisbon, and sharing this stimulating, interactive, and educational program with you.